EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Allosteric modulation of M1 or M4 muscarinic receptors restores eNOS expression and L-arginine metabolism in dementia models and synergizes with NO releasers

Agata Płoska, Adrianna Radulska, Anna Siekierzycka, Paulina Cieślik, Michał Santocki, Iwona T Dobrucki, Leszek Kalinowski, Joanna M Wierońska

Pharmacology Biochemistry and Behavior · 2025

DOI: 10.1016/j.pbb.2025.174085 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology Biochemistry and Behavior, 2025. Verfasst von Agata Płoska und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Diagnostics- Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland. Ele…. Hauptthemen laut MEDLINE: Arginine, Nitric Oxide Synthase Type III, Nitric Oxide, Receptor, Muscarinic M1. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 74 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Science Centre Poland, Republic of Poland Ministry of Science and Higher Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Positive allosteric modulators (PAMs) of muscarinic receptors (M) have been shown to effectively prevent cognitive dysfunctions associated with dementias, but little is known about their impact on NO֗-dependent pathways, in particular eNOS expression, L-arginine metabolism and its derivatives (ADMA/SDMA/NMMA) production. METHODS: Biochemical studies were performed in frontal cortices, hippocampi and plasma samples from mice that were administered with MK-801 (schizophrenia-related dementa) or scopolamine (Alzheimer's disease model) for 14 days alone or together with muscarinic receptors modulators: VU0357017 (M1) and VU0152100 (M4). Western blot was used to measure eNOS, DDAH1 and PRMT5, while mass spectrometry was used to measure the levels of L-arginine derivatives. Behavioral studies aimed to investigate the procognitive effects of the combined administration of PAMs with NO• releasers, spermineNONOate or DETANONOate were performed in novel object recognition (NOR) test, in scopolamine- or MK-801- induced amnesia. RESULTS: Our results indicate that MK-801 or scopolamine disturb eNOS, DDAH1, PRMT5 expression, and L-arginine bioavailability. VU0357017 or VU0152100 prevented scopolamine or MK-801-induced eNOS dysfunction, but L-arginine derivatives synthesis was inhibited only in MK-801 model. Synergistic effect with NO֗ releasers was observed in NOR. CONCLUSIONS: eNOS expression and L-arginine bioavailability may contribute to antipsychotic action of VU0357017 or VU0152100. The antialzheimer's effect to a lesser extend involves normalization of L-arginine metabolism. The joint administration of the compounds with NO֗ releaser could be proposed as synergistic treatment for both schizophrenia and Alzheimer's disease.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ArginineNitric Oxide Synthase Type IIINitric OxideReceptor, Muscarinic M1Receptor, Muscarinic M4DementiaAnimalsMiceMaleAllosteric RegulationDisease Models, AnimalDizocilpine MaleateScopolamineDrug SynergismMice, Inbred C57BLAmidohydrolases

Stichwörter der Autor:innen

Cognitive declineL-arginineMuscarineNORNitric oxide

Substanzen

ArginineNitric Oxide Synthase Type IIINitric OxideReceptor, Muscarinic M1Receptor, Muscarinic M4Dizocilpine MaleateScopolaminedimethylargininaseNos3 protein, mouseAmidohydrolases

Autor:innen und Institutionen

  • Department of Medical Laboratory Diagnostics- Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland. Electronic address: agata.ploska@gumed.edu.pl.
  • Department of Medical Laboratory Diagnostics- Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland. Electronic address: adrianna.radulska@gumed.edu.pl.
  • Department of Medical Laboratory Diagnostics- Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland. Electronic address: anna.siekierzycka@gumed.edu.pl.
  • Maj Institute of Pharmacology, Polish Academy of Sciences, 12 Smetna Street, 31-343 Krakow, Poland.
  • Department of Bioengineering, University of Illinois at Urbana-Champaign, Urbana, IL, USA; Beckman Institute for Advanced Science and Technology, Urbana, IL, USA; Department of Biomedical and Translational Sciences, Car…
  • Department of Medical Laboratory Diagnostics- Fahrenheit Biobank BBMRI.pl, Medical University of Gdansk, 7 Debinki Street, 80-211 Gdansk, Poland; BioTechMed Center, Department of Mechanics of Materials and Structures, G…

Förderung

  • National Science Centre Poland
  • Republic of Poland Ministry of Science and Higher Education

Zitieren

APA

Płoska, A., Radulska, A., Siekierzycka, A., Cieślik, P., Santocki, M., Dobrucki, I. T., Kalinowski, L., & Wierońska, J. M. (2025). Allosteric modulation of M1 or M4 muscarinic receptors restores eNOS expression and L-arginine metabolism in dementia models and synergizes with NO releasers. Pharmacology Biochemistry and Behavior. https://doi.org/10.1016/j.pbb.2025.174085

Vancouver

Płoska A, Radulska A, Siekierzycka A, Cieślik P, Santocki M, Dobrucki IT, et al. Allosteric modulation of M1 or M4 muscarinic receptors restores eNOS expression and L-arginine metabolism in dementia models and synergizes with NO releasers. Pharmacology Biochemistry and Behavior. 2025. doi:10.1016/j.pbb.2025.174085

BibTeX
@article{Poska2025,
  author = {Płoska, Agata and Radulska, Adrianna and Siekierzycka, Anna and Cieślik, Paulina and Santocki, Michał and Dobrucki, Iwona T and Kalinowski, Leszek and Wierońska, Joanna M},
  title = {Allosteric modulation of M1 or M4 muscarinic receptors restores eNOS expression and L-arginine metabolism in dementia models and synergizes with NO releasers},
  journal = {Pharmacology Biochemistry and Behavior},
  year = {2025},
  doi = {10.1016/j.pbb.2025.174085}
}
Kostenlos starten →